FDG PET/CT in Dendritic Fibromyxolipoma of the Thigh
We describe FDG PET/CT and MRI findings of a dendritic fibromyxolipoma incidentally detected in a case with rectal adenocarcinoma. The dendritic fibromyxolipoma showed inhomogeneous FDG uptake with SUVmax of 4.0 mimicking malignancy. (Source: Clinical Nuclear Medicine)
Source: Clinical Nuclear Medicine - January 16, 2022 Category: Nuclear Medicine Tags: Interesting Images Source Type: research

High Expression MicroRNA-206 Inhibits the Growth of Tumor Cells in Human Malignant Fibrous Histiocytoma
Conclusion: Hsa-miR-206 played a key role in regulating MFH CSC properties that might be a representative marker and target for the diagnosis and treatment of MFH in the future.PMID:34900997 | PMC:PMC8656228 | DOI:10.3389/fcell.2021.751833 (Source: Cancer Control)
Source: Cancer Control - December 13, 2021 Category: Cancer & Oncology Authors: Dejian Li Kai Zhao Ziwen Zhao Bo Jiang Xianxu Gong Yan Zhang Yingqi Guo Han Xiao Ye Wang Hui Liu Chengqing Yi Wenguang Gu Source Type: research

Atypical Fibroxanthoma Demonstrating HMB45+ Staining
We report a case of AFX which was strongly positive for HMB45, but negative for all other melanocytic markers. This case emphasizes the potential pitfall of relying on a single immunohistochemical marker to make the diagnosis, especially of melanoma, and also is one of the only rare reported cases of AFXs which are HMB45+. (Source: The American Journal of Dermatopathology)
Source: The American Journal of Dermatopathology - November 26, 2021 Category: Pathology Tags: Extraordinary Case Report Source Type: research

Case Report: Review of CT Findings and Histopathological Characteristics of Primary Liver Carcinosarcoma
Conclusions: CT characteristics observed in the present study were of great benefit for the diagnosis of PLCS. (Source: Frontiers in Genetics)
Source: Frontiers in Genetics - June 17, 2021 Category: Genetics & Stem Cells Source Type: research

Pulmonary metastasectomy in soft tissue sarcomas: a systematic review
CONCLUSIONS: Complete resection of the metastatic lesions seems to be the most effective treatment for long-term survival, or even achieving cure in selected patients. At selection of the patients amenable for surgery, a high probability of R0 resection, as well as a disease free period of at least 12 months should perhaps bear a higher specific value.PMID:34012614 | PMC:PMC8107546 | DOI:10.21037/jtd-2019-pm-13 (Source: Journal of Thoracic Disease)
Source: Journal of Thoracic Disease - May 20, 2021 Category: Respiratory Medicine Authors: Davor Stamenovic Peter Hohenberger Eric Roessner Source Type: research